Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine plus esketamine serratus anterior plane block in perimenopausal women undergoing mastectomy
ChiCTR2600118835Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Jiangnan University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in climacteric, postoperative pain, Negative affect and 1 more (3 arms), sponsored by Affiliated Hospital of Jiangnan University. Primary endpoints: VAS score, NRS score and 2 more. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
climactericpostoperative painNegative affectdelirium
Beyond the preview
Go deeper on ChiCTR2600118835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118835.